Long-Term Safety of Canakinumab in Patients with Gouty Arthritis.

被引：0
|
作者：
So, Alexander [1 ]
Alten, Reike [2 ]
Schumacher, H. Ralph [3 ,4 ]
Bloch, Mark [5 ]
Bardin, Thomas [6 ]
John, Markus R. [7 ]
Krammer, Gerhard [7 ]
Nebesky, Jan Michael [7 ]
Tao, Aiyang [8 ]
Schlesinger, Naomi [9 ]
机构：
[1] Univ Lausanne, CHUV, Lausanne, Switzerland
[2] Charite, D-13353 Berlin, Germany
[3] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[4] VA Med Ctr, Philadelphia, PA USA
[5] Holdsworth House Med Practice, Sydney, NSW, Australia
[6] Hop Lariboisiere, F-75475 Paris, France
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] UMDNJ RWJMS, New Brunswick, NJ USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
144
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [1] Long-Term Efficacy and Safety of Canakinumab Versus Triamcinolone Acetonide in Acute Gouty Arthritis Patients.
    Brown, J. P.
    So, A.
    Dikranian, A.
    Alten, R.
    Bardin, T.
    Schumacher, H. R.
    Gimona, A.
    Krammer, G.
    Karpov, A.
    Schlesinger, N.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S396 - S396
  • [2] Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Long-Term Safety and Efficacy Results from a 36-Week Extension Study
    Sunkureddi, Prashanth
    Moericke, Ruediger
    Toth, Edith
    Brown, Jacques P.
    Machein, Uwe
    Lheritier, Karine
    Junge, Guido
    Kivitz, Alan J.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [3] LONG-TERM SAFETY AND MAINTENANCE OF EFFICACY OF CANAKINUMAB LIQUID FORMULATION IN ACUTE GOUTY ARTHRITIS PATIENTS: RESULTS FROM A 36 WEEK EXTENSION STUDY
    Moricke, R.
    Sunkureddi, P.
    Toth, E.
    Brown, J. P.
    Machein, U.
    Lheritier, K.
    Junge, G.
    Kivitz, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1209 - 1210
  • [4] Long-term efficacy and safety of meloxicam in juvenile rheumatoid arthritis.
    Foeldvari, I
    Burgos-Vargas, R
    Thon, A
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S121 - S121
  • [5] Long-Term Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis
    Alexeeva, Ekaterina
    Denisova, Rina
    Dvoryakovskaya, Tatyana
    Isaeva, Ksenia
    Kriulin, Ivan
    Alshevskaya, Alina
    Moskalev, Andrey
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [6] LONG-TERM SAFETY AND EFFICACY OF CANAKINUMAB VS TRIAMCINOLONE ACETONIDE IN PATIENTS WITH FREQUENT ACUTE GOUTY ARTHRITIS ATTACKS WHO ARE CONTRAINDICATED, INTOLERANT OR UNRESPONSIVE TO NSAIDS AND/OR COLCHICINE
    Alten, R.
    Schlesinger, N.
    So, A.
    Schumacher, H. R.
    Bloch, M. T.
    Machein, U.
    Richard, D.
    Lheritier, K.
    Bardin, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 785 - 785
  • [7] Long-term prognosis of patients with juvenile idiopathic arthritis.
    Minden, K
    Niewerth, M
    Listing, J
    Zink, A
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S119 - S119
  • [8] Long-term safety of canakinumab in systemic JIA
    McHugh J.
    Nature Reviews Rheumatology, 2018, 14 (11) : 622 - 622
  • [9] Long Term Safety and Efficacy of Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Results from a 36 Week Extension Study.
    Sunkureddi, P.
    Toth, E.
    Brown, J. P.
    Moericke, R.
    Richard, D.
    Lheritier, K.
    Stancati, A.
    Kivitz, A.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S73 - S73
  • [10] EFFICACY AND SAFETY OF CANAKINUMAB IN GOUTY ARTHRITIS PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE ≥3
    Sunkureddi, P.
    Bardin, T.
    Alten, R.
    Schlesinger, N.
    Bloch, M.
    Kiechle, T.
    Krammer, G.
    Shpilsky, A.
    So, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 447 - 448
12345